US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network
Published . Updated .
Key takeaways
- The United States has announced new sanctions against Italy’s ’Ndrangheta , targeting its leadership in Canada and associated businesses as part of a broader crackdown on international narcotics trafficking.
- Exposed: EWI, EWC, XLV, XBI, LLY
- Market reaction: EWC −0.7% on the day (still updating); EWI −0.2% on the day (still updating); MRK −2.4% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
The United States has announced new sanctions against Italy’s ’Ndrangheta , targeting its leadership in Canada and associated businesses as part of a broader crackdown on international narcotics trafficking. The November 19 operation, carried out by the Treasury Department’s
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- EWI iShares MSCI Italy ETF-2.2% 6d
iShares MSCI Italy ETF holds stocks listed in Italy, which this story is about (“italy”).
- EWC iShares MSCI Canada ETF+3.3% 30d
iShares MSCI Canada ETF holds stocks listed in Canada, which this story is about (“canada”).
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | +3.66% | +3.71% | base | -2.06% | after close | after close | after close |
| XBI | +4.22% | +0.59% | base | +1.01% | after close | after close | after close |
| EWI | +4.22% | +2.79% | base | -0.21% | after close | after close | after close |
| EWC | +5.00% | +3.48% | base | -0.66% | after close | after close | after close |
| LLY | +3.43% | +3.72% | base | -1.44% | after close | after close | after close |
| JNJ | +3.98% | +3.63% | base | -2.02% | after close | after close | after close |
| PFE | +2.74% | +2.92% | base | -1.09% | after close | after close | after close |
| MRK | +6.65% | +4.90% | base | -2.37% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network Decode39
Source: Decode39
Select Sector Spdr Tr (XLV)
Select Sector Spdr Tr (XLV) the next day, across 3 earlier stories: average -3.45%, largest gain -3.45%, largest drop -3.45%, from 3 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Select Sector Spdr Tr (XLV) | the next day | -3.45% | -3.45% | -3.45% | 3 |
| Spdr Series Trust (XBI) | the next day | +1.76% | +1.76% | +1.76% | 2 |
| Eli Lilly (LLY) | the next day | -3.25% | -3.25% | -3.25% | 2 |
The price since 19 Nov 2026: Select Sector Spdr Tr (XLV) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| EWC | that day | -0.66% | still updating |
| EWC | three days earlier | +3.48% | final price |
| EWC | five days earlier | +5.00% | final price |
| Ishares (EWI) | that day | -0.21% | still updating |
| Ishares (EWI) | three days earlier | +2.79% | final price |
| Ishares (EWI) | five days earlier | +4.22% | final price |
| Johnson & Johnson (JNJ) | that day | -2.02% | still updating |
| Johnson & Johnson (JNJ) | three days earlier | +3.63% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +3.98% | final price |
| Eli Lilly (LLY) | that day | -1.44% | still updating |
| Eli Lilly (LLY) | three days earlier | +3.72% | final price |
| Eli Lilly (LLY) | five days earlier | +3.43% | final price |
| Merck (MRK) | that day | -2.37% | still updating |
| Merck (MRK) | three days earlier | +4.90% | final price |
| Merck (MRK) | five days earlier | +6.65% | final price |
| Pfizer (PFE) | that day | -1.09% | still updating |
| Pfizer (PFE) | three days earlier | +2.92% | final price |
| Pfizer (PFE) | five days earlier | +2.74% | final price |
| Spdr Series Trust (XBI) | that day | +1.01% | still updating |
| Spdr Series Trust (XBI) | three days earlier | +0.59% | final price |
| Spdr Series Trust (XBI) | five days earlier | +4.22% | final price |
| Select Sector Spdr Tr (XLV) | that day | -2.06% | still updating |
| Select Sector Spdr Tr (XLV) | three days earlier | +3.71% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +3.66% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 16 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 30 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 43 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 50 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 90 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies tied to this story
- XLV Select Sector Spdr Tr
In “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story
- XBI Spdr Series Trust
For “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story
- EWI Ishares
Ishares (EWI) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network.” Reason on file: iShares MSCI Italy ETF holds stocks listed in Italy, which this story is about (“italy”)
- LLY Eli Lilly
For “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network.” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story
- PFE Pfizer
In “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network.” Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
“US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network” (19 Nov 2026) reaches Select Sector Spdr Tr (XLV) through this story.
What ties Select Sector Spdr Tr (XLV) to the headline is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story
Also listed, Spdr Series Trust (XBI): SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story
Price levels for Select Sector Spdr Tr (XLV)
EWI traded between 55.42 and 58.09 across 6 sessions. The latest close on file is 56.65.
What the saved facts support for Select Sector Spdr Tr (XLV)
46 out of 100Price not final
“US sanctions Italy’s ’Ndrangheta, targeting its global drug trafficking network” scores 46 out of 100. The score uses 1 source, and 7 linked companies. The price is not final yet.